We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPFR.U
3026
DELISTED
JAWS Spitfire Acquisition Corp Units, each consisting of one Class A ordinary share, and one-fourth
SPFR.U
-200,000
Closed -$2.21M
QELL
3027
DELISTED
Qell Acquisition Corp. Class A Ordinary Shares
QELL
-13,878
Closed -$171K
TBIO
3028
DELISTED
Translate Bio, Inc. Common Stock
TBIO
-35,485
Closed -$654K
SHSP
3029
DELISTED
SharpSpring, Inc.
SHSP
-11,231
Closed -$183K
PFPT
3030
DELISTED
Proofpoint, Inc.
PFPT
-25,375
Closed -$3.46M
AJAX.U
3031
DELISTED
Capri Listco Units, each consisting of one Class A ordinary share and one-fourth of one redeemable w
AJAX.U
-1,200,000
Closed -$14.9M
RMGBU
3032
DELISTED
RMG Acquisition Corp. II Unit
RMGBU
-300,000
Closed -$3.35M
QS.WS
3033
CALL
DELISTED
QuantumScape Corporation Warrants, each whole warrant exercisable for one share of Class A common st
QS.WS
-68,747
Closed -$5.81M
NEBCU
3034
DELISTED
Nebula Caravel Acquisition Corp. Unit
NEBCU
-400,000
Closed -$4.32M
CAP.U
3035
DELISTED
Capitol Investment Corp. V Units, each consisting of one share of Class A common stock, and one-thir
CAP.U
-900,000
Closed -$9.27M
ALSK
3036
DELISTED
Alaska Communications Systems
ALSK
-68,038
Closed -$251K
RAACU
3037
DELISTED
Revolution Acceleration Acquisition Corp Unit
RAACU
-333,333
Closed -$3.47M
DCRBU
3038
DELISTED
Decarbonization Plus Acquisition Corporation Unit
DCRBU
-650,000
Closed -$7.47M
CNST
3039
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
-56,991
Closed -$1.64M
SPRQ.U
3040
DELISTED
Spartan Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-ha
SPRQ.U
-356,056
Closed -$3.85M
MSGN
3041
DELISTED
MSG Networks Inc.
MSGN
-12,192
Closed -$180K
FSKR
3042
DELISTED
FS KKR Capital Corp. II
FSKR
-21,951
Closed -$360K
LEAF
3043
DELISTED
Leaf Group Ltd.
LEAF
-50,601
Closed -$235K
TSIAU
3044
DELISTED
TS Innovation Acquisitions Corp. Unit
TSIAU
-250,000
Closed -$2.63M
STIC.U
3045
DELISTED
Northern Star Acquisition Corp. Units, each consisting of one share of common stock and one-third of
STIC.U
-250,000
Closed -$3.92M
IPOE.U
3046
DELISTED
Social Capital Hedosophia Holdings Corp. V Units, each consisting of one Class A ordinary share and
IPOE.U
-193,846
Closed -$2.56M
NBLX
3047
DELISTED
Noble Midstream Partners LP
NBLX
-37,738
Closed -$393K
NGA
3048
DELISTED
Northern Genesis Acquisition Corp.
NGA
-56,462
Closed -$1M
WDR
3049
DELISTED
Waddell & Reed Financial, Inc.
WDR
-157,288
Closed -$4.01M
STPK.WS
3050
CALL
DELISTED
Star Peak Energy Transition Corp. Warrants, each whole warrant exercisable for one share of Class A
STPK.WS
-199,995
Closed -$4.09M

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.